Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients

Samir Gupta, B. W. Mamlin, C. S. Johnson, M. D. Dollins, J. M. Topf, M. P. Dubé

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Aims: HIV-related renal diseases are increasingly prevalent and are associated with proteinuria and rapid progression to end-stage renal failure. Early treatment with highly active antiretroviral therapy (HAART) and ACE inhibition may prevent the development of chronic kidney disease (CKD), but studies evaluating the epidemiology of proteinuria and early CKD in HIV-infected patients are lacking. Methods: All consecutive patients at Wishard Memorial Hospital (Indiana University) whose initial HIV documentation occurred from 1990 to 1998, were retrospectively studied using a computerized medical record system. Clinical data were abstracted from time of first HIV documentation through 12/31/2000. The proportions of patients who developed CKD (doubling of serum creatinine from an initial level ≤ 1.5 mg/dl) and who had proteinuria (≥ 1+ protein on the first urine dipstick after HIV documentation) were calculated. Case mix and laboratory variables at the time of HIV documentation were compared between those who did and did not develop CKD and between those who had and did not have initial proteinuria. Results: Of 487 subjects with initially normal renal function, 10 (2% (95% CI, 1 - 4%)) developed CKD. In univariable analysis, black race, a diagnosis of diabetes or hypertension and proteinuria were all significantly associated with the development of CKD; 89 (29% (95% CI, 24 - 35%)) of 289 evaluable subjects had ≥ 1+ proteinuria on urine analysis. Multivariable regression revealed only older age (OR 1.08 per year increase; 95% CI, 1.03 - 1.14) to be associated with proteinuria. Conclusions: A small, but potentially clinically meaningful proportion of HIV-infected patients develop CKD, and there appears to be a high prevalence of proteinuria on the first urine analysis obtained after HIV documentation.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalClinical Nephrology
Volume61
Issue number1
StatePublished - Jan 2004

Fingerprint

Chronic Renal Insufficiency
Proteinuria
HIV
Documentation
Urine
Computerized Medical Records Systems
Kidney
Diagnosis-Related Groups
Highly Active Antiretroviral Therapy
Chronic Kidney Failure
Creatinine
Epidemiology
Hypertension
Serum
Proteins

Keywords

  • Chronic kidney disease
  • Epidemiology
  • HIV
  • Nephropathy
  • Proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this

Gupta, S., Mamlin, B. W., Johnson, C. S., Dollins, M. D., Topf, J. M., & Dubé, M. P. (2004). Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clinical Nephrology, 61(1), 1-6.

Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. / Gupta, Samir; Mamlin, B. W.; Johnson, C. S.; Dollins, M. D.; Topf, J. M.; Dubé, M. P.

In: Clinical Nephrology, Vol. 61, No. 1, 01.2004, p. 1-6.

Research output: Contribution to journalArticle

Gupta, S, Mamlin, BW, Johnson, CS, Dollins, MD, Topf, JM & Dubé, MP 2004, 'Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients', Clinical Nephrology, vol. 61, no. 1, pp. 1-6.
Gupta, Samir ; Mamlin, B. W. ; Johnson, C. S. ; Dollins, M. D. ; Topf, J. M. ; Dubé, M. P. / Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. In: Clinical Nephrology. 2004 ; Vol. 61, No. 1. pp. 1-6.
@article{8239d2bc674a4dbd97276f5a6000c697,
title = "Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients",
abstract = "Aims: HIV-related renal diseases are increasingly prevalent and are associated with proteinuria and rapid progression to end-stage renal failure. Early treatment with highly active antiretroviral therapy (HAART) and ACE inhibition may prevent the development of chronic kidney disease (CKD), but studies evaluating the epidemiology of proteinuria and early CKD in HIV-infected patients are lacking. Methods: All consecutive patients at Wishard Memorial Hospital (Indiana University) whose initial HIV documentation occurred from 1990 to 1998, were retrospectively studied using a computerized medical record system. Clinical data were abstracted from time of first HIV documentation through 12/31/2000. The proportions of patients who developed CKD (doubling of serum creatinine from an initial level ≤ 1.5 mg/dl) and who had proteinuria (≥ 1+ protein on the first urine dipstick after HIV documentation) were calculated. Case mix and laboratory variables at the time of HIV documentation were compared between those who did and did not develop CKD and between those who had and did not have initial proteinuria. Results: Of 487 subjects with initially normal renal function, 10 (2{\%} (95{\%} CI, 1 - 4{\%})) developed CKD. In univariable analysis, black race, a diagnosis of diabetes or hypertension and proteinuria were all significantly associated with the development of CKD; 89 (29{\%} (95{\%} CI, 24 - 35{\%})) of 289 evaluable subjects had ≥ 1+ proteinuria on urine analysis. Multivariable regression revealed only older age (OR 1.08 per year increase; 95{\%} CI, 1.03 - 1.14) to be associated with proteinuria. Conclusions: A small, but potentially clinically meaningful proportion of HIV-infected patients develop CKD, and there appears to be a high prevalence of proteinuria on the first urine analysis obtained after HIV documentation.",
keywords = "Chronic kidney disease, Epidemiology, HIV, Nephropathy, Proteinuria",
author = "Samir Gupta and Mamlin, {B. W.} and Johnson, {C. S.} and Dollins, {M. D.} and Topf, {J. M.} and Dub{\'e}, {M. P.}",
year = "2004",
month = "1",
language = "English",
volume = "61",
pages = "1--6",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "1",

}

TY - JOUR

T1 - Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients

AU - Gupta, Samir

AU - Mamlin, B. W.

AU - Johnson, C. S.

AU - Dollins, M. D.

AU - Topf, J. M.

AU - Dubé, M. P.

PY - 2004/1

Y1 - 2004/1

N2 - Aims: HIV-related renal diseases are increasingly prevalent and are associated with proteinuria and rapid progression to end-stage renal failure. Early treatment with highly active antiretroviral therapy (HAART) and ACE inhibition may prevent the development of chronic kidney disease (CKD), but studies evaluating the epidemiology of proteinuria and early CKD in HIV-infected patients are lacking. Methods: All consecutive patients at Wishard Memorial Hospital (Indiana University) whose initial HIV documentation occurred from 1990 to 1998, were retrospectively studied using a computerized medical record system. Clinical data were abstracted from time of first HIV documentation through 12/31/2000. The proportions of patients who developed CKD (doubling of serum creatinine from an initial level ≤ 1.5 mg/dl) and who had proteinuria (≥ 1+ protein on the first urine dipstick after HIV documentation) were calculated. Case mix and laboratory variables at the time of HIV documentation were compared between those who did and did not develop CKD and between those who had and did not have initial proteinuria. Results: Of 487 subjects with initially normal renal function, 10 (2% (95% CI, 1 - 4%)) developed CKD. In univariable analysis, black race, a diagnosis of diabetes or hypertension and proteinuria were all significantly associated with the development of CKD; 89 (29% (95% CI, 24 - 35%)) of 289 evaluable subjects had ≥ 1+ proteinuria on urine analysis. Multivariable regression revealed only older age (OR 1.08 per year increase; 95% CI, 1.03 - 1.14) to be associated with proteinuria. Conclusions: A small, but potentially clinically meaningful proportion of HIV-infected patients develop CKD, and there appears to be a high prevalence of proteinuria on the first urine analysis obtained after HIV documentation.

AB - Aims: HIV-related renal diseases are increasingly prevalent and are associated with proteinuria and rapid progression to end-stage renal failure. Early treatment with highly active antiretroviral therapy (HAART) and ACE inhibition may prevent the development of chronic kidney disease (CKD), but studies evaluating the epidemiology of proteinuria and early CKD in HIV-infected patients are lacking. Methods: All consecutive patients at Wishard Memorial Hospital (Indiana University) whose initial HIV documentation occurred from 1990 to 1998, were retrospectively studied using a computerized medical record system. Clinical data were abstracted from time of first HIV documentation through 12/31/2000. The proportions of patients who developed CKD (doubling of serum creatinine from an initial level ≤ 1.5 mg/dl) and who had proteinuria (≥ 1+ protein on the first urine dipstick after HIV documentation) were calculated. Case mix and laboratory variables at the time of HIV documentation were compared between those who did and did not develop CKD and between those who had and did not have initial proteinuria. Results: Of 487 subjects with initially normal renal function, 10 (2% (95% CI, 1 - 4%)) developed CKD. In univariable analysis, black race, a diagnosis of diabetes or hypertension and proteinuria were all significantly associated with the development of CKD; 89 (29% (95% CI, 24 - 35%)) of 289 evaluable subjects had ≥ 1+ proteinuria on urine analysis. Multivariable regression revealed only older age (OR 1.08 per year increase; 95% CI, 1.03 - 1.14) to be associated with proteinuria. Conclusions: A small, but potentially clinically meaningful proportion of HIV-infected patients develop CKD, and there appears to be a high prevalence of proteinuria on the first urine analysis obtained after HIV documentation.

KW - Chronic kidney disease

KW - Epidemiology

KW - HIV

KW - Nephropathy

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=0346505360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346505360&partnerID=8YFLogxK

M3 - Article

C2 - 14964451

AN - SCOPUS:0346505360

VL - 61

SP - 1

EP - 6

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 1

ER -